Publication | Open Access

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

Experimental Human CancerOncologyAnti-tumour EfficacyMedicinePharmacotherapyAnti-cancer AgentMetronomic ChemotherapyCancer TreatmentPharmacologyCancer Research